Ticker: ALLO

Company: Allogene Therapeutics, Inc.

Person: DEBORAH M MESSEMER, director

Transaction date: Dec. 9, 2024

Reporting date: Dec. 10, 2024

Average share price: 2.18

Sold 9136.0 shares for 19916.48